文献速递心力衰竭与心肌病心律失常

欧洲心脏病学会心肌病注册研究:成人患者基线特征与当代管理

The Cardiomyopathy Registry of the EURObservational Research Programme of the European Society of Cardiology: baseline data and contemporary management of adult patients with cardiomyopathies.
PubMed 文献 · Eur Heart J · 2018-01-01

该前瞻性、观察性、多国注册研究纳入18国69中心连续3208例成人心肌病患者的四种亚型(HCM 1739例、DCM 1260例、ARVC 143例、RCM 66例),报告基线特征与管理。不同亚型在诊断年龄、家族史、持续性室性心律失常史、MRI或基因检测使用及除颤器植入方面存在差异(P<0.001)。注册研究为评估指南实施提供平台。

要点

  • 四种心肌病亚型在诊断年龄、家族史、心律失常史及器械植入上差异显著(P<0.001)。
  • 与先证者相比,亲属诊断年龄更低(P<0.001),但症状和除颤器植入率相似。
  • 参与中心经验及地理区域影响家族性疾病诊断和器械植入率。

核心结论

  • 注册研究提供当代心肌病患者特征与管理观察数据,为评估指南实施提供平台,并讨论现有推荐差距及改进建议。

研究设计与样本

  • 前瞻性、观察性、多国注册研究,纳入18国69中心连续3208例成人心肌病患者,包括HCM(n=1739)、DCM(n=1260)、ARVC(n=143)和RCM(n=66)。

主要发现

  • 不同心肌病亚型在诊断年龄、家族性疾病史、持续性室性心律失常史、MRI或基因检测使用及除颤器植入方面差异有统计学意义(P<0.001)。
  • 与先证者相比,亲属诊断年龄更低(P<0.001),但症状和除颤器植入率相似。
  • 与长期阶段相比,试点阶段(入组于更专业中心)患者家族性疾病率更高(P<0.001)、罕见基础病诊断更频繁(P<0.001)、除颤器植入更频繁(P=0.023)。
  • 南欧患者家族性疾病更频繁(P<0.001)、更常在家族筛查中诊断(P<0.001)、罕见基础病诊断更频繁(P<0.001)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: The Cardiomyopathy Registry of the EURObservational Research Programme is a prospective, observational, and multinational registry of consecutive patients with four cardiomyopathy subtypes: hypertrophic cardiomyopathy (HCM), dilated cardiomyopathy (DCM), arrhythmogenic right ventricular cardiomyopathy (ARVC), and restrictive cardiomyopathy (RCM). We report the baseline characteristics and management of adults enrolled in the registry. METHODS AND RESULTS: A total of 3208 patients were enrolled by 69 centres in 18 countries [HCM (n = 1739); DCM (n = 1260); ARVC (n = 143); and RCM (n = 66)]. Differences between cardiomyopathy subtypes (P < 0.001) were observed for age at diagnosis, history of familial disease, history of sustained ventricular arrhythmia, use of magnetic resonance imaging or genetic testing, and implantation of defibrillators. When compared with probands, relatives had a lower age at diagnosis (P < 0.001), but a similar rate of symptoms and defibrillators. When compared with the Long-Term phase, patients of the Pilot phase (enrolled in more expert centres) had a more frequent rate of familial disease (P < 0.001), were more frequently diagnosed with a rare underlying disease (P < 0.001), and more frequently implanted with a defibrillator (P = 0.023). Comparing four geographical areas, patients from Southern Europe had a familial disease more frequently (P < 0.001), were more frequently diagnosed in the context of a family screening (P < 0.001), and more frequently diagnosed with a rare underlying disease (P < 0.001). CONCLUSION: By providing contemporary observational data on characteristics and management of patients with cardiomyopathies, the registry provides a platform for the evaluation of guideline implementation. Potential gaps with existing recommendations are discussed as well as some suggestions for improvement of health care provision in Europe.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Charron P, Elliott PM, Gimeno JR, et al. The Cardiomyopathy Registry of the EURObservational Research Programme of the European Society of Cardiology: baseline data and contemporary management of adult patients with cardiomyopathies. Eur Heart J. 2018. PMID: 29378019. doi:10.1093/eurheartj/ehx819

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。